[HTML][HTML] Dose-escalated stereotactic body radiation therapy for prostate cancer: Quality-of-life comparison of two prospective trials

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - frontiersin.org
Introduction The optimal prostate stereotactic body radiation therapy (SBRT) dose-
fractionation scheme is controversial. This study compares long-term quality of life (QOL) …

[PDF][PDF] Dose-Escalated Stereotactic Body radiation Therapy for Prostate Cancer: Quality-of-life Comparison of Two Prospective Trials

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - core.ac.uk
Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life
Comparison of Two Prospective Trials Page 1 August 2016 | Volume 6 | Article 185 1 CliniCal …

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials

HC Quon, HB Musunuru, P Cheung… - Frontiers in …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction The optimal prostate stereotactic body radiation therapy (SBRT) dose-
fractionation scheme is controversial. This study compares long-term quality of life (QOL) …

[HTML][HTML] Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - ncbi.nlm.nih.gov
Results One hundred fourteen patients were included, 84 treated with 35 Gy and 30 treated
with 40 Gy. Median QOL follow-up was 56 months [interquartile range (IQR) 46–60] and 38 …

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials.

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - europepmc.org
Results One hundred fourteen patients were included, 84 treated with 35 Gy and 30 treated
with 40 Gy. Median QOL follow-up was 56 months [interquartile range (IQR) 46-60] and 38 …

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials.

HC Quon, HB Musunuru, P Cheung, G Pang… - Frontiers in …, 2016 - europepmc.org
Results One hundred fourteen patients were included, 84 treated with 35 Gy and 30 treated
with 40 Gy. Median QOL follow-up was 56 months [interquartile range (IQR) 46-60] and 38 …